Cytomx Therapeutics, Inc.盘中异动临近收盘股价大跌5.09%

市场透视10-26

北京时间2024年10月26日03时59分，Cytomx Therapeutics, Inc.（CTMX.us）股票出现波动，股价大幅跳水5.09%。截至发稿，该股报1.03美元/股，成交量125.237万股，换手率1.60%，振幅5.56%。最近的财报数据显示，该股实现营业收入25.12百万美元，净利润-6.53百万美元，每股收益-0.08美元，毛利24.66百万美元，市盈率6.87倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2478796647?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-26 03:59","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2478796647","market":"us","top_or_hot":-1,"title":"Cytomx Therapeutics, Inc.盘中异动 临近收盘股价大跌5.09%","media":"市场透视","content":"<div>\n<p>北京时间2024年10月26日03时59分，Cytomx Therapeutics, Inc.（CTMX.us）股票出现波动，股价大幅跳水5.09%。截至发稿，该股报1.03美元/股，成交量125.237万股，换手率1.60%，振幅5.56%。最近的财报数据显示，该股实现营业收入25.12百万美元，净利润-6.53百万美元，每股收益-0.08美元，毛利24.66百万美元，市盈率6.87倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026035948a1eb36d8&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cytomx Therapeutics, Inc.盘中异动 临近收盘股价大跌5.09%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCytomx Therapeutics, Inc.盘中异动 临近收盘股价大跌5.09%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-26 03:59 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026035948a1eb36d8&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年10月26日03时59分，Cytomx Therapeutics, Inc.（CTMX.us）股票出现波动，股价大幅跳水5.09%。截至发稿，该股报1.03美元/股，成交量125.237万股，换手率1.60%，振幅5.56%。最近的财报数据显示，该股实现营业收入25.12百万美元，净利润-6.53百万美元，每股收益-0.08美元，毛利24.66百万美元，市盈率6.87倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026035948a1eb36d8&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026035948a1eb36d8&s=b","article_id":"2478796647","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026035948a1eb36d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2478796647","pubTimestamp":1729886388,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年10月26日03时59分，Cytomx Therapeutics, Inc.股票出现波动，股价大幅跳水5.09%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Iterum Therapeutics Plc、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Iterum Therapeutics Plc较为活跃，换手率分别为878.28%、800.23%、452.19%，振幅较大的相关个股有Iterum Therapeutics Plc、Elevai Labs, Inc.、Qualigen Therapeutics, Inc.，振幅分别为102.56%、93.82%、91.58%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","LENZ":"Therapeutics","CTMX":"CytomX"},"translate_title":"Cytomx Therapeutics, Inc. 's intraday movement plunged 5.09% near the close","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CTMX":1,"LENZ":1},"content_text":"北京时间2024年10月26日03时59分，Cytomx Therapeutics, Inc.（CTMX.us）股票出现波动，股价大幅跳水5.09%。截至发稿，该股报1.03美元/股，成交量125.237万股，换手率1.60%，振幅5.56%。最近的财报数据显示，该股实现营业收入25.12百万美元，净利润-6.53百万美元，每股收益-0.08美元，毛利24.66百万美元，市盈率6.87倍。机构评级方面，在所有7家参与评级的机构中，57%的券商给予买入建议，43%的券商给予持有建议，无券商给予卖出建议。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 (To Pur Com)、Iterum Therapeutics Plc、Pasithea Therapeutics Corp C/Wts 12/08/2026 (To Pur Com)涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Iterum Therapeutics Plc较为活跃，换手率分别为878.28%、800.23%、452.19%，振幅较大的相关个股有Iterum Therapeutics Plc、Elevai Labs, Inc.、Qualigen Therapeutics, Inc.，振幅分别为102.56%、93.82%、91.58%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。 该公司致力于开发基于probody技术平台的抗体疗法。 该公司的probody技术平台针对临床验证的靶点创建专有的癌症免疫疗法，并开发癌症疗法。probody疗法旨在利用肿瘤微环境中的条件来增强抗体的肿瘤靶向特性并降低健康组织中的药物活性。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2478796647"}

Cytomx Therapeutics, Inc.盘中异动 临近收盘股价大跌5.09%

精彩评论

Cytomx Therapeutics, Inc.盘中异动临近收盘股价大跌5.09%